https://doi.org/10.1186/s12943-019-1125-9
X
Xiaoli Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
270
Papers
4.6K
Citations
39
h-index
116
i10-index
Xiaoli Li is an academic researcher from Fujian Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 39, co-authored 230 publications.
ORCID: 0000-0001-8106-2358Papers by this author
worksRoles of circRNAs in the tumour microenvironment
2020 · Molecular Cancer · 279 citations
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
2019 · Journal of Cellular Physiology · 113 citations
https://doi.org/10.1002/jcp.28918
Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling
2015 · BMC Cell Biology · 63 citations
https://doi.org/10.1186/s12860-015-0067-3
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
2016 · BMC Cancer · 48 citations
https://doi.org/10.1186/s12885-016-2941-6
Lactate and Lactylation in Sepsis: A Comprehensive Review
2024 · Journal of Inflammation Research · 40 citations
https://doi.org/10.2147/jir.s459185
Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness
2022 · Journal of Experimental & Clinical Cancer Research · 31 citations
https://doi.org/10.1186/s13046-022-02375-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat